<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Parallel determinations of muscarinic cholinergic M1 receptor (M1-R) binding and of M1-R <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels were carried out in the gerbil hippocampus 14 days after 5 min of <z:e sem="disease" ids="C0022118" disease_type="Disease or Syndrome" abbrv="">transient ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Both were reduced in the ischemic tissue to about 50% of the levels found in sham-operated controls, indicating that the late loss of M1-R is probably dependent on decreased synthesis </plain></SENT>
<SENT sid="2" pm="."><plain>Three administrations of bifemelane <z:chebi fb="16" ids="36807">hydrochloride</z:chebi> (15 mg/kg, i.p., just after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and 6 and 12 h later) completely prevented neuronal <z:hpo ids='HP_0011420'>death</z:hpo> in the hippocampus and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced losses of hippocampal M1-R and its <z:chebi fb="2" ids="33699">mRNA</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Since vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> may depend upon the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced losses in cholinergic communication in the hippocampus, these findings suggest that it may be possible to prevent its occurrence by post-ischemic treatment with bifemelane <z:chebi fb="16" ids="36807">hydrochloride</z:chebi> </plain></SENT>
</text></document>